Impact of the COVID-19 pandemic on results and financial position
First written in FY2021-Q1. 8 of 15 entries say "Restated". Latest entry: FY2026-H1.
The whole theme swung hardest in 2020: 112 of 175 companies on the "Worse" side.
56 other companies' latest entry also says "Mitigated".
- FY2026-H1MitigatedAnnual report
「The aerospace sector remained on a steady course, supported by the recovery in air passenger demand, which had declined during the COVID-19 pandemic, and moves to strengthen defense capabilities worldwide.」
The disclosure states that the recovery in air passenger demand, which had been depressed by the COVID-19 pandemic, continued and that the aerospace sector remained firm. The impact of the previous decline in demand caused by the infectious disease eased further. - FY2025-H1RestatedAnnual report
「Although air-passenger demand, which had been sluggish during the COVID-19 pandemic, recovered, the aerospace business remained in an adjustment phase due to the impact of efforts to rebuild the industry's supply chain, including labor shortages.」
While recognising the recovery in air passenger demand, which had been depressed by the COVID-19 pandemic, adjustment conditions continued in the aerospace sector due to the impact of efforts to rebuild the supply chain. - FY2025-Q1MitigatedAnnual report
「Air passenger demand, which had been depressed by the COVID-19 pandemic, recovered」
The disclosure states that air passenger demand, which had been depressed by the COVID-19 pandemic, recovered, indicating that the impact of the spread of the novel coronavirus disease on aviation-related demand eased further. - FY2024MitigatedAnnual report
「While economic activity improved amid the recovery in human mobility, including inbound travel, and the reclassification of the novel coronavirus disease as a Category 5 infectious disease」
The disclosure states that economic activity improved as human mobility recovered and COVID-19 was reclassified as a Category 5 infectious disease, continuing to indicate a shift toward normalisation from the previous impact of the spread of infection and restrictions on behaviour. - FY2024-Q1MitigatedAnnual report
「While economic activity improved amid the recovery in human mobility, including inbound travel, and the reclassification of the novel coronavirus disease as a Category 5 infectious disease」
The disclosure states that economic activity improved as COVID-19 was reclassified as a Category 5 infectious disease and human mobility recovered, indicating a shift toward normalisation from the previous impact of the spread of infection and restrictions on behaviour. - FY2023-Q3RestatedAnnual report
「During the first 3 quarters of the current fiscal year (1 March 2022 to 30 November 2022), the global economy showed signs of recovery toward normalisation from the impact of the spread of the novel coronavirus disease (hereinafter, COVID-19), although」
The explanation continues to state that while the impact of COVID-19 persisted, economic activity was recovering toward normalisation. - FY2023-Q2RestatedAnnual report
「As priority preventive measures to stop the spread of the novel coronavirus disease (hereinafter, COVID-19) were lifted and economic activity began to normalise」
While the disclosure describes the lifting of COVID-19-related measures and the move toward normalisation of economic activity, uncertainty in the business environment, including the impact of the infectious disease, has continued. - FY2023-Q1MitigatedAnnual report
「During the first quarter of the current fiscal year (1 March 2022 to 31 May 2022), the Japanese economy was moving toward normalisation as priority preventive measures to stop the spread of the novel coronavirus disease (hereinafter, COVID-19) were lifted and economic activity began to normalise」
The disclosure states that while the impact of COVID-19 on economic activity continued, priority preventive measures to stop the spread of the disease were lifted and economic activity was moving toward normalisation. - FY2022RestatedAnnual report
「However, the Group's performance was affected by factors including the significant decline in revenue, particularly in our aircraft engine components business, amid the overall stagnation of economic activity and weak global demand for aircraft. The global spread of COVID-19 has yet to subside and may continue to have a significant impact on the Group's performance.」
The continued disclosure states that weak aircraft demand due to COVID-19 and declining sales in the aircraft engine components business remained actual factors affecting performance, while the possibility of future impacts was also retained. - FY2022-Q3RestatedAnnual report
「The global economy during the cumulative consolidated period recorded significant negative growth due to the spread of COVID-19. Although signs of recovery emerged, particularly in Western countries, as vaccination rates increased, concerns remain about the spread of infections caused by new variants.」
While recognizing increases in vaccination rates and the normalization of economic activity, the report continues to note concerns about the spread of infections caused by new variants and the ongoing effects of COVID-19. - FY2022-Q2RestatedAnnual report
「Japan's economy has been significantly affected by economic activity restrictions, including renewed declarations of a state of emergency and the implementation of priority preventive measures in some regions due to the resurgence of COVID-19. Although some positive signs, such as progress in vaccinations, have emerged, the outlook remains uncertain.」
The effects of COVID-19 on economic activity and uncertainty over the outlook continue, although positive factors such as progress in vaccinations and signs of recovery in the aerospace business were also reported. - FY2022-Q1RestatedAnnual report
「Japan's economy was significantly affected by the resurgence of COVID-19, including the re-declaration of a state of emergency and implementation of priority preventive measures in certain regions. At the same time, some positive signs were emerging, including the start of vaccinations, but the outlook remained uncertain.」
Although the effects of COVID-19 continued, recovery factors such as the start of vaccinations were also noted. - FY2021-Q3RestatedAnnual report
「The effects of the spread of COVID-19 were felt in all regions during the nine months ended the third quarter. Details are provided in “2. Analysis of Financial Position, Operating Results and Cash Flows by Management, (1) Analysis of Operating Results.”」
The explanation that the effects of COVID-19 had extended to all regions continues. The main text provides further details on weak performance and the recognition of losses in the aerospace, housing, transportation-related, and machinery-sales businesses. - FY2021-Q2WorsenedAnnual report
「The effects of the spread of COVID-19 were felt in all regions during the six months ended the second quarter. Details are provided in “2. Analysis of Financial Position, Operating Results and Cash Flows by Management, (1) Analysis of Operating Results and (7) Factors Affecting Operating Results Materially and the Company's Response and Outlook.”」
The report explicitly stated that the effects of COVID-19 had extended to all regions, further detailing the impact on actual operating results and financial position, including production cuts in major markets, operating losses, and the reversal of deferred tax assets. - FY2021-Q1First statedAnnual report
「The spread of COVID-19 could affect the Group's financial position and results. However, as there are currently many uncertain and undetermined factors, we will closely monitor developments.」
The possibility that the spread of COVID-19 could affect the Group's financial position and results was first explicitly identified as a business risk.